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limitation of experimental models. We do agree that extrapolation
to humans has to be done cautiously, as discussed in our study.
The main point of our study was to demonstrate that electrical
capture of myocardium, under specific circumstances, can occur
after neuromuscular incapacitating device (NID) discharge. Unless
the recording system is shielded from electromechanical interfer-
ence, accurate assessment of cardiac effects of discharges is not
possible, and conclusions about the safety of discharges are
unreliable. We did not draw conclusions about reports of the
possible consequences of NID discharges reported in the media,
but we wanted to highlight the potential for myocardial capture
and potential risks of high-frequency cardiac stimulation under
specific (and likely very uncommon in usual use) circumstances.
We agree that it is not possible to directly extrapolate our results to
NID use in humans.
The letter by Kroll et al. highlights the same difficulties, with
regard to coming to safety conclusions based on the absence of
objectively documented arrhythmias predicated on interviews and
making surface recordings in humans. This line of argument
regarding safety in humans can be misleading; as we have shown in
our experiments, immediately before and after the NID discharge
there was no observable cardiac stimulation. However, if one is
able to “see through” the electrical artifact during the discharge,
cardiac stimulation was seen. Until intracardiac recordings can be
made in humans with shielding to obliterate the electrical artifact
that obscures possible intracardiac events, making safety conclu-
sions in humans is premature. We did not state that NIDs cause
ventricular fibrillation in humans, and we agree that we cannot
conclude from our study that NID discharges cause arrhythmias in
typical use.
We hope that readers agree that our study does suggest the
possibility that NIDs may, in some circumstances, cause cardiac
capture, and that this possibility should at least be considered in
future research in humans. We hope that our work stimulates such
research, using similar methods, in this area in humans.
Paul Dorian, MD
*Kumaraswamy Nanthakumar, MD
*University of Toronto
Cardiology
Toronto General Hospital
150 Gerrard Street West
PMCC 3-522
Toronto, Ontario M5C 2C4
Canada
doi:10.1016/j.jacc.2006.11.020
REFERENCE
1. Nanthakumar K, Billingsley IM, Masse S, et al. Cardiac electrophysi-
ological consequences of neuromuscular incapacitating device dis-
charges. J Am Coll Cardiol 2006;48:798–804.
Reply
Although it is always best to test a device or a drug in humans, such
testing is not necessarily feasible in all situations. Extensive tests,
such as those performed to assess the effects of electrode positions
and drug effects, are all but impossible except in an anesthetized
animal model. Animal models have been used in many studies and
have contributed to our understanding of many physiologic pro-
cesses directly applicable to human beings. The pig model, for
example, has been extensively used in studying defibrillation in
internal or external defibrillators. Those findings have extrapolated
well to human beings.
However, human studies have limitations. Thus, we (1) would
differ from Dr. Pippin’s broad indictment of animal studies as not
being useful. Controversy exists in field reports of whether elec-
trical stun guns have the potential, although infrequent, of directly
causing ventricular arrhythmias. Human studies are limited in
nature. Multiple exposures to the stun gun, prolonged exposure,
seeking the most vulnerable thoracic sites, or safety margin of stun
gun exposure would be impossible to perform in a human
population. Monitoring of heart beats with transvenous electrodes
would also be difficult to assess in a healthy group of human
volunteers. The relationship of ventricular capture to induction of
ventricular fibrillation (VF), for example, would have been difficult
to assess in humans. The margin of safety and its relationship to
thoracic position of the darts would also be difficult to assess.
Although animals clearly do have a different anatomy, factors
related to anatomic differences such as distance from the chest wall
to the heart can be assessed.
We would also differ with Dr. Pippin’s assessment that the
cocaine findings are in contradiction to the common impression
that cocaine causes arrhythmias. Cocaine may cause coronary
spasm and an increase in sympathetic tone. Both of these effects
can lead to arrhythmias. Our findings are clearly stated (1).
Cocaine reduces the ability of a stun gun to induce VF. We were
careful to note that the sedated state may minimize some of the
sympathetic responses associated with cocaine ingestion. However,
given the manner by which VF is induced with the stun gun
impulses, via ventricular capture, it is quite physiologic to expect
that cocaine would actually increase VF induction thresholds. This
finding would have been difficult to confirm in a human study.
Finally, although one always has to be careful in extending
results of animal studies to humans, such findings are extremely
helpful in understanding mechanisms and in directing potentially
acceptable studies in humans that would further our understanding
and facilitate increased safety or efficacy of the tested object.
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